Healthcare Industry News:  ezetimibe/simvastatin 

Biopharmaceuticals Cardiology

 News Release - March 13, 2006

Data Analysis Showed VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced LDL ''bad'' Cholesterol and C-reactive Protein (CRP) in Patients with High Cholesterol Compared to Zocor(R) (simvastatin)

Source: Merck-Schering Plough

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.